Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors

被引:60
作者
Eltabbakh, GH
Shamonki, J
Mount, SL
机构
[1] Lake Champlain Gynecol Oncol, S Burlington, VT 05403 USA
[2] Univ Vermont, Dept Pathol, S Burlington, VT 05403 USA
关键词
endometrial carcinoma; survival; well-differentiated tumors;
D O I
10.1016/j.ygyno.2005.06.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The purpose of our study was to assess the surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy showed well-differentiated (FIGO grade I) carcinoma. Materials and methods. A retrospective study was conducted including all women treated at the University of Vermont between 1992 and 2004 whose preoperative endometrial biopsy was reviewed by the staff at the Pathology Department and diagnosed as FIGO grade I adenocarcinoma and who received peritoneal washings, total abdominal (or laparoscopic) hysterectomy, bilateral salpingo-oophorectomy, and pelvic para-aortic lymphadenectomy as part of their Surgery. Results. One hundred eighty-two patients (age: 32-91, median: 60) were enrolled. All patients had total hysterectomy, bilateral salpingo-oophorectomy, peritoneal washings, and bilateral pelvic lymphadenectomy. Fifteen (8.2%) patients had para-aortic lymphadenectomy. There were no operative mortalities. Fourteen patients (7.7%) had major operative or postoperative complications. There was disagreement between the pre- and postoperative grade in 30% of the Study group. The surgical stages were: IA: 55 (30.2%), IB: 61 (33.5%), IC: 26 (14.3%), IIA: 9 (4.9%), IIB: 8 (4.4%), IIIA: 10 (5.5%), IIIB: 2 (1.1%) IIIC: 8 (4.4%), and IV: 3 (1.6%). Postoperatively, 131 (72%) patients received no additional treatment, 47 (25.8%) received radiation therapy, 3 (1.6%) received chemotherapy, and 1 (0.5%) received Megace. During a median follow-up period of 6 years, 8 (4.4%) patients had recurrence and 6 (3.2%) died from their disease. The 5-year disease-free and overall Survival was 95.2% and 96.4%, respectively. Conclusions. Approximately 30% of women with endometrial carcinoma whose preoperative endometrial biopsy shows grade I tumors have grade 2 or 3 in the hysterectomy specimen and 12.6% have advanced Surgical stage (stage III and IV) disease. Women with preoperative endometrial biopsy showing grade 1 tumors who undergo surgical staging have excellent survival and acceptable operative morbidity. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:309 / 312
页数:4
相关论文
共 17 条
[1]  
ABELER VM, 1991, CANCER, V67, P3093, DOI 10.1002/1097-0142(19910615)67:12<3093::AID-CNCR2820671226>3.0.CO
[2]  
2-L
[3]  
Announcements, 1989, Gynecologic Oncology, V35, P125, DOI [DOI 10.1016/0090-8258(89)90027-9, 10.1016/0090-8258(89)90027-9]
[4]   Surgical staging for patients presenting with grade 1 endometrial carcinoma [J].
Ben-Shachar, I ;
Pavelka, J ;
Cohn, DE ;
Copeland, LJ ;
Ramirez, N ;
Manolitsas, T ;
Fowler, JM .
OBSTETRICS AND GYNECOLOGY, 2005, 105 (03) :487-493
[5]   Race and clinical outcome in endometrial carcinoma [J].
Connell, PP ;
Rotmensch, J ;
Waggoner, SE ;
Mundt, AJ .
OBSTETRICS AND GYNECOLOGY, 1999, 94 (05) :713-720
[6]  
CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO
[7]  
2-8
[8]  
DANIEL AG, 1988, OBSTET GYNECOL, V71, P612
[9]   Effect of grade on disease-free survival and overall survival in FIGO stage I adenocarcinoma of the endometrium [J].
Delaloye, JF ;
Pampallona, S ;
Coucke, PA ;
Megalo, A ;
De Grandi, P .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2000, 88 (01) :75-80
[10]   Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer [J].
Frumovitz, M ;
Slomovitz, BM ;
Singh, DK ;
Broaddus, RR ;
Abrams, J ;
Sun, CC ;
Bevers, M ;
Bodurka, DC .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2004, 199 (03) :388-393